|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0409 USD | +16.86% |
|
+16.86% | +38.64% |
| 05-25 | Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-30 | Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | -47.38 | -106.51 | -527.61 | -425.32 | -509.64 | ||||
Return on Total Capital | -49.96 | -140.26 | 191.31 | 46.73 | 37.42 | ||||
Return On Equity % | -125.51 | -254.83 | 221.25 | 52.36 | 49.52 | ||||
Return on Common Equity | -125.51 | -254.83 | 221.25 | 52.36 | 49.52 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | -292.67 | 97.07 | 69.86 | 75.71 | 58.63 | ||||
SG&A Margin | 344.55 | 584.47 | 1.13K | 485.89 | 838.93 | ||||
EBITDA Margin % | -674.15 | -534.68 | -1.23K | -421.25 | -878.02 | ||||
EBITA Margin % | -677.71 | -539.55 | -1.24K | -423.12 | -881.14 | ||||
EBIT Margin % | -677.71 | -539.55 | -1.24K | -423.12 | -881.14 | ||||
Income From Continuing Operations Margin % | -1.06K | -574.76 | -1.31K | -402.95 | -929.86 | ||||
Net Income Margin % | -1.06K | -574.76 | -1.31K | -402.95 | -929.86 | ||||
Net Avail. For Common Margin % | -1.06K | -574.76 | -1.31K | -402.95 | -929.86 | ||||
Normalized Net Income Margin | -458.93 | -359.22 | -836.32 | -251.84 | -581.16 | ||||
Levered Free Cash Flow Margin | -81.55 | -243.51 | -38.26 | -12.16 | 126.9 | ||||
Unlevered Free Cash Flow Margin | -81.55 | -243.24 | -6.9 | 15.4 | 173.26 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.11 | 0.32 | 0.68 | 1.61 | 0.93 | ||||
Fixed Assets Turnover | 14.22 | 16.05 | 16.08 | - | - | ||||
Receivables Turnover (Average Receivables) | 3.58 | 2.09 | 2.2 | 8.08 | 4.59 | ||||
Inventory Turnover (Average Inventory) | 1.98 | 1.28 | 1.91 | 1.19 | - | ||||
Short Term Liquidity | |||||||||
Current Ratio | 11.89 | 0.59 | 0.11 | 0.06 | 0.05 | ||||
Quick Ratio | 11.63 | 0.53 | 0.08 | 0.03 | 0.05 | ||||
Operating Cash Flow to Current Liabilities | -13.9 | -3.95 | -0.47 | -0.15 | -0.05 | ||||
Days Sales Outstanding (Average Receivables) | 101.91 | 174.4 | 165.8 | 45.31 | 79.46 | ||||
Days Outstanding Inventory (Average Inventory) | 183.97 | 284.8 | 191.19 | 306.67 | - | ||||
Average Days Payable Outstanding | 25.38K | 3.66K | 435.38 | 873.86 | - | ||||
Cash Conversion Cycle (Average Days) | -25.09K | -3.2K | -78.39 | -521.87 | - | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | - | -49.59 | -29.54 | -24.62 | -19.4 | ||||
Total Debt / Total Capital | - | -98.37 | -41.92 | -32.66 | -24.07 | ||||
LT Debt/Equity | - | -21.78 | -2.8 | - | - | ||||
Long-Term Debt / Total Capital | - | -43.2 | -3.98 | - | - | ||||
Total Liabilities / Total Assets | 8.28 | 179.09 | 948.12 | 1.81K | 1.86K | ||||
EBIT / Interest Expense | - | -1.27K | -24.69 | -9.59 | -11.88 | ||||
EBITDA / Interest Expense | - | -1.26K | -24.58 | -9.55 | -11.84 | ||||
(EBITDA - Capex) / Interest Expense | - | -1.26K | -24.58 | -9.55 | -11.84 | ||||
Total Debt / EBITDA | - | -0.06 | -0.25 | -0.56 | -0.47 | ||||
Net Debt / EBITDA | 0.43 | -0.02 | -0.19 | -0.56 | -0.35 | ||||
Total Debt / (EBITDA - Capex) | - | -0.06 | -0.25 | -0.56 | -0.47 | ||||
Net Debt / (EBITDA - Capex) | 0.43 | -0.02 | -0.19 | -0.56 | -0.35 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | -70.01 | -38.58 | -55.17 | 82.8 | -40.04 | ||||
Gross Profit, 1 Yr. Growth % | -226.41 | -120.37 | -67.74 | 98.12 | -53.57 | ||||
EBITDA, 1 Yr. Growth % | 62.22 | -51.29 | 3.43 | -37.58 | 24.98 | ||||
EBITA, 1 Yr. Growth % | 61.59 | -51.1 | 2.93 | -37.56 | 24.87 | ||||
EBIT, 1 Yr. Growth % | 61.59 | -51.1 | 2.93 | -37.56 | 24.87 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 102.03 | -66.83 | 2.4 | -43.9 | 38.37 | ||||
Net Income, 1 Yr. Growth % | 102.03 | -66.83 | 2.4 | -43.9 | 38.37 | ||||
Normalized Net Income, 1 Yr. Growth % | 45.85 | -51.93 | 4.37 | -44.95 | 38.37 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 83.4 | -66.83 | -0.79 | -51.37 | 35.96 | ||||
Accounts Receivable, 1 Yr. Growth % | 68.2 | -32.42 | -94.32 | 726.68 | -81.8 | ||||
Inventory, 1 Yr. Growth % | -99.55 | -42.12 | 644.84 | 67.24 | - | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | -41.23 | -52.99 | -60.01 | - | - | ||||
Total Assets, 1 Yr. Growth % | -76.32 | -86.38 | -26.69 | -16.89 | 29.61 | ||||
Tangible Book Value, 1 Yr. Growth % | -70.16 | -111.75 | 686.12 | 67.22 | 33.81 | ||||
Common Equity, 1 Yr. Growth % | -77.28 | -111.75 | 686.12 | 67.22 | 33.81 | ||||
Cash From Operations, 1 Yr. Growth % | -36.05 | -24.27 | -49.91 | -46.78 | -57.25 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | -82.17 | 83.39 | -92.96 | -41.89 | -725.64 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -82 | 83.19 | -98.73 | -508.1 | 574.52 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | -13.75 | -57.08 | -47.53 | -9.47 | 4.7 | ||||
Gross Profit, 2 Yr. CAGR % | 52.27 | -49.26 | -74.36 | -20.05 | -4.09 | ||||
EBITDA, 2 Yr. CAGR % | 34.85 | -11.11 | -29.02 | -19.65 | -11.67 | ||||
EBITA, 2 Yr. CAGR % | 35 | -11.11 | -29.06 | -19.84 | -11.7 | ||||
EBIT, 2 Yr. CAGR % | 35 | -11.11 | -29.06 | -19.84 | -11.7 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 69.22 | -18.14 | -41.72 | -24.2 | -11.89 | ||||
Net Income, 2 Yr. CAGR % | 69.22 | -18.14 | -41.72 | -24.2 | -11.89 | ||||
Normalized Net Income, 2 Yr. CAGR % | 40.57 | -16.27 | -29.17 | -24.2 | -12.72 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 25.56 | -22 | -42.63 | -30.54 | -18.69 | ||||
Accounts Receivable, 2 Yr. CAGR % | 29.97 | 6.62 | -80.4 | -31.47 | 22.67 | ||||
Inventory, 2 Yr. CAGR % | -81.03 | -94.89 | 107.62 | 252.94 | - | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -36.09 | -47.44 | -56.64 | - | - | ||||
Total Assets, 2 Yr. CAGR % | -35.31 | -82.04 | -68.4 | -21.95 | 3.78 | ||||
Tangible Book Value, 2 Yr. CAGR % | -9.95 | -81.28 | -3.9 | 262.56 | 49.58 | ||||
Common Equity, 2 Yr. CAGR % | -30.87 | -83.66 | -3.9 | 262.56 | 49.58 | ||||
Cash From Operations, 2 Yr. CAGR % | -3.59 | -30.41 | -38.41 | -48.37 | -52.31 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | -48.08 | -42.81 | -64.06 | -79.77 | 90.67 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -47.25 | -42.57 | -84.74 | -77.22 | 424.66 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 32.63 | -22.98 | -56.45 | -20.46 | -21.09 | ||||
Gross Profit, 3 Yr. CAGR % | 99.84 | -22.12 | -56.37 | -49.32 | -33.3 | ||||
EBITDA, 3 Yr. CAGR % | - | -3.96 | -6.5 | -32 | -6.9 | ||||
EBITA, 3 Yr. CAGR % | 54.58 | -3.77 | -6.66 | -32.02 | -7.07 | ||||
EBIT, 3 Yr. CAGR % | 54.58 | -3.77 | -6.66 | -32.02 | -7.07 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 67.61 | -1.7 | -11.79 | -42.45 | -7.36 | ||||
Net Income, 3 Yr. CAGR % | 67.61 | -1.7 | -11.79 | -42.45 | -7.36 | ||||
Normalized Net Income, 3 Yr. CAGR % | 48.11 | -1.7 | -9.89 | -34.88 | -7.36 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 37.21 | -19.43 | -15.49 | -45.71 | -13.12 | ||||
Accounts Receivable, 3 Yr. CAGR % | 25.44 | 4.51 | -59.88 | -31.78 | -55.95 | ||||
Inventory, 3 Yr. CAGR % | -46.09 | -72.48 | -73.11 | 93.18 | - | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | -42.31 | -52.02 | - | - | ||||
Total Assets, 3 Yr. CAGR % | -34.38 | -61.51 | -71.3 | -56.38 | -7.57 | ||||
Tangible Book Value, 3 Yr. CAGR % | -23.59 | -54.33 | -34.93 | 15.58 | 160.06 | ||||
Common Equity, 3 Yr. CAGR % | -31.42 | -61.71 | -40.58 | 15.58 | 160.06 | ||||
Cash From Operations, 3 Yr. CAGR % | 32.25 | -11.04 | -37.63 | -41.34 | -51.52 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | 3.17 | -20.93 | -71.55 | -57.82 | -36.5 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 9.4 | -20.12 | -83.87 | -54.36 | -29.53 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 35.62 | -8.47 | -17.84 | -38.15 | ||||
Gross Profit, 5 Yr. CAGR % | - | 34.82 | -12.11 | -21.3 | -40.21 | ||||
EBITDA, 5 Yr. CAGR % | - | - | - | -10.57 | -8.61 | ||||
EBITA, 5 Yr. CAGR % | - | 43.47 | 13.2 | -10.55 | -8.71 | ||||
EBIT, 5 Yr. CAGR % | - | 43.47 | 13.2 | -10.55 | -8.71 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 39.99 | 9.85 | -11.41 | -11.83 | ||||
Net Income, 5 Yr. CAGR % | - | 39.99 | 9.85 | -11.41 | -11.83 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 39.99 | 10.27 | -11.41 | -11.03 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | -14.79 | -3.19 | -24.08 | -16.79 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 33.52 | -40.31 | -11.72 | -37.26 | ||||
Inventory, 5 Yr. CAGR % | - | - | -7.55 | -23.65 | - | ||||
Total Assets, 5 Yr. CAGR % | - | -34.93 | -51.01 | -48.93 | -52 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 14.91 | -16.25 | 4.6 | -9.22 | ||||
Common Equity, 5 Yr. CAGR % | - | -31.88 | -21.51 | -5.9 | -14.04 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 36.07 | -2.58 | -28.44 | -43.98 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | -32.33 | -54.16 | -39.1 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | -50.24 | -51.64 | -35.07 |
- Stock Market
- Stocks
- OVAT Stock
- OVATF Stock
- Financials Ovation Science Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















